Ki67-Adjusted Mitotic Score (KAMS): a novel prognostic metric in well-differentiated pancreatic neuroendocrine tumors Pubblico
Riaz, Ansa (2017)
Abstract
Introduction: The grading of PanNETs presents numerous
diagnostic challenges and limits our ability to accurately predict
their clinical behavior. The current WHO grading system uses Ki67
index (KI) and/or mitotic count (MC) to obtain a histological grade
(G1, G2, G3) for tumors. However, there are numerous ambiguities in
this grading system, including different scales of measurement of
Ki67 and mitosis, sub-optimal categorical cut-offs and lack of
consensus on best counting methodologies. To fully exploit the
prognosticating power of both KI and MC, we rationally integrated
them and derived a new metric, Ki67-adjusted mitotic score (KAMS),
which represents the proportion of mitotic cells amongst cycling
Ki67-positive tumor cells.
Methods: Among 97 PanNETs KAMS was calculated by
transforming monotonic ordinal MC into % mitotic cells and dividing
it by % Ki67. Survival stratification was done via Kaplan-Meier
estimator based on KAMS and KI.
Results: Using current established thresholds in PanNET
grading, the survival stratification for KI showed significance
between high (Grade 3) and low (Grade 1) Ki67 survival percentages
(p=0.02). However, KAMS was able to stratify patients into two
statistically significant survival groups (p= 0.04): The
"above-threshold KAMS" group had 74% survival while the
"below-threshold KAMS" group had a 53% survival. The ideal
threshold of KAMS was .0033.
Conclusion: This study underscores the significance of our new metric, KAMS, to provide a more accurate risk prediction in PanNETs. Low KAMS significantly predict poor prognosis in PanNETs and is superior to Ki67 in survival stratification. Although validation of the KAMS score in other larger datasets is warranted, it appears that KAMS could significantly improve PanNETs prognostic risk determination by identifying individuals at higher risk of progressing to metastatic disease.
Table of Contents
CHAPTER 1: Literature Review and Introduction: .................1
Epidemiology in the United States .....................1
Global Burden.................................................4
Clinical Background.........................................8
Treatment Options..........................................9
Grading and Related Issues.............................10
Research Question .........................................13
CHAPTER 2: Manuscript...................................................14
Abstract.......................................................15
Introduction..................................................16
Methods........................................................18
Results..........................................................19
Discussion.....................................................,24
References......................................................27
CHAPTER 3: Public Health Implications..............................28
REFERENCES.................................................................30
About this Master's Thesis
School | |
---|---|
Department | |
Degree | |
Submission | |
Language |
|
Research Field | |
Parola chiave | |
Committee Chair / Thesis Advisor | |
Partnering Agencies |
Primary PDF
Thumbnail | Title | Date Uploaded | Actions |
---|---|---|---|
Ki67-Adjusted Mitotic Score (KAMS): a novel prognostic metric in well-differentiated pancreatic neuroendocrine tumors () | 2018-08-28 16:16:46 -0400 |
|
Supplemental Files
Thumbnail | Title | Date Uploaded | Actions |
---|